[
  {
    "ts": null,
    "headline": "Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics",
    "summary": "While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=5af05921f14720439addc2ed78b4cd6cd0ae5143ee2aeb742115a24b0269ba08",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746135006,
      "headline": "Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics",
      "id": 134184911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=5af05921f14720439addc2ed78b4cd6cd0ae5143ee2aeb742115a24b0269ba08"
    }
  },
  {
    "ts": null,
    "headline": "Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates",
    "summary": "Amgen (AMGN) delivered earnings and revenue surprises of 17.79% and 2.47%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=e663f9cf3fbdf2a99d5a796ee63ab438aef1c60fc44ab9a2469c45658832009f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746133805,
      "headline": "Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates",
      "id": 134184912,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) delivered earnings and revenue surprises of 17.79% and 2.47%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=e663f9cf3fbdf2a99d5a796ee63ab438aef1c60fc44ab9a2469c45658832009f"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN) Q1 2025 Earnings Call Transcript",
    "summary": "Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsJustin Claeys - VP, IRRobert Bradway - Chairman, CEO...",
    "url": "https://finnhub.io/api/news?id=fd44bd388f0ce1e4925b1e6037f955178a9dca26d1489e94a2dd303d49048ea6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746132139,
      "headline": "Amgen Inc. (AMGN) Q1 2025 Earnings Call Transcript",
      "id": 134178556,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsJustin Claeys - VP, IRRobert Bradway - Chairman, CEO...",
      "url": "https://finnhub.io/api/news?id=fd44bd388f0ce1e4925b1e6037f955178a9dca26d1489e94a2dd303d49048ea6"
    }
  },
  {
    "ts": null,
    "headline": "Amgen beats Q1 expectations, issues solid full-year outlook",
    "summary": "Investing.com - Amgen Inc (NASDAQ:AMGN) reported better-than-expected first-quarter results, driven by strong demand for its products globally.",
    "url": "https://finnhub.io/api/news?id=e44ae5576aa45209e89d6e957fea8f7412fa98346b0b81e4432cfc948ad0b1bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746132077,
      "headline": "Amgen beats Q1 expectations, issues solid full-year outlook",
      "id": 134184913,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Investing.com - Amgen Inc (NASDAQ:AMGN) reported better-than-expected first-quarter results, driven by strong demand for its products globally.",
      "url": "https://finnhub.io/api/news?id=e44ae5576aa45209e89d6e957fea8f7412fa98346b0b81e4432cfc948ad0b1bc"
    }
  },
  {
    "ts": null,
    "headline": "Amgen posts profit, says tax policy more effective than tariffs",
    "summary": "(Reuters) -Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to speculate on the impact of U.S. tariffs, tax policy would be a more effective way to influence U.S. manufacturing.  President Donald Trump's administration has opened a national security investigation into pharmaceuticals in a bid to demonstrate why the U.S. needs tariffs to increase domestic manufacturing.  \"We agree with our peers that the most effective answer is not tariffs, but tax policy,\" Amgen CFO Peter Griffith said on a conference call.",
    "url": "https://finnhub.io/api/news?id=9a1ec53a7edc01a4d69c5c77fda7b83e7d0049308cefc5cc28a78bacd370cf16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746130977,
      "headline": "Amgen posts profit, says tax policy more effective than tariffs",
      "id": 134184914,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "(Reuters) -Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to speculate on the impact of U.S. tariffs, tax policy would be a more effective way to influence U.S. manufacturing.  President Donald Trump's administration has opened a national security investigation into pharmaceuticals in a bid to demonstrate why the U.S. needs tariffs to increase domestic manufacturing.  \"We agree with our peers that the most effective answer is not tariffs, but tax policy,\" Amgen CFO Peter Griffith said on a conference call.",
      "url": "https://finnhub.io/api/news?id=9a1ec53a7edc01a4d69c5c77fda7b83e7d0049308cefc5cc28a78bacd370cf16"
    }
  },
  {
    "ts": null,
    "headline": "Amgen beats Q1 earnings, revenue estimates. Stock flat.",
    "summary": "Amgen (AMGN) eked past first quarter revenue estimates, posting $8.15 billion (vs. estimates of $8.05 billion), while blowing past adjusted earnings per share forecasts with a figure of $4.90 (vs. estimates of $4.25). Yahoo Finance senior health reporter Anjalee Khemlani comes on Market Domination Overtime to dive deeper into these numbers. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=93c921fdd04d64e71f9d00373201501c2f388913e94b6646062a5d881cebcb8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746130804,
      "headline": "Amgen beats Q1 earnings, revenue estimates. Stock flat.",
      "id": 134184915,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) eked past first quarter revenue estimates, posting $8.15 billion (vs. estimates of $8.05 billion), while blowing past adjusted earnings per share forecasts with a figure of $4.90 (vs. estimates of $4.25). Yahoo Finance senior health reporter Anjalee Khemlani comes on Market Domination Overtime to dive deeper into these numbers. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=93c921fdd04d64e71f9d00373201501c2f388913e94b6646062a5d881cebcb8b"
    }
  },
  {
    "ts": null,
    "headline": "Amgen: Q1 Earnings Snapshot",
    "summary": "AMGN) on Thursday reported first-quarter net income of $1.73 billion, after reporting a loss in the same period a year earlier. On a per-share basis, the Thousand Oaks, California-based company said it had net income of $3.20. Earnings, adjusted for non-recurring costs, came to $4.90 per share.",
    "url": "https://finnhub.io/api/news?id=6e0d756ba107b01f9cb613d049144c0b0e4a9a45ef5a6674811eefd460de0c04",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746130113,
      "headline": "Amgen: Q1 Earnings Snapshot",
      "id": 134184916,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "AMGN) on Thursday reported first-quarter net income of $1.73 billion, after reporting a loss in the same period a year earlier. On a per-share basis, the Thousand Oaks, California-based company said it had net income of $3.20. Earnings, adjusted for non-recurring costs, came to $4.90 per share.",
      "url": "https://finnhub.io/api/news?id=6e0d756ba107b01f9cb613d049144c0b0e4a9a45ef5a6674811eefd460de0c04"
    }
  },
  {
    "ts": null,
    "headline": "Amgen’s (NASDAQ:AMGN) Q1: Beats On Revenue",
    "summary": "Biotech company Amgen (NASDAQ:AMGN) announced better-than-expected revenue in Q1 CY2025, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to analysts’ estimates. Its non-GAAP profit of $4.90 per share was 15% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=a8ce6616a4f5bc3dd74dd358ad6ac834ee5740e98ddde09def21ea1a098aa04e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746130055,
      "headline": "Amgen’s (NASDAQ:AMGN) Q1: Beats On Revenue",
      "id": 134184917,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Biotech company Amgen (NASDAQ:AMGN) announced better-than-expected revenue in Q1 CY2025, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to analysts’ estimates. Its non-GAAP profit of $4.90 per share was 15% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=a8ce6616a4f5bc3dd74dd358ad6ac834ee5740e98ddde09def21ea1a098aa04e"
    }
  },
  {
    "ts": null,
    "headline": "AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS",
    "summary": "Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=03aff009201e03341552b9b11e996786f6ad500c5b0dc78acc4bd1fb1205d881",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746129660,
      "headline": "AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS",
      "id": 134184918,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=03aff009201e03341552b9b11e996786f6ad500c5b0dc78acc4bd1fb1205d881"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. 2025 Q1 - Results - Earnings Call Presentation",
    "summary": "Amgen Inc. 2025 Q1 - Results - Earnings Call Presentation",
    "url": "https://finnhub.io/api/news?id=b440e8ac5a3fdc8c2a96587abfbb7872e5470ae85fef17b965b53ed89f268e0e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746119396,
      "headline": "Amgen Inc. 2025 Q1 - Results - Earnings Call Presentation",
      "id": 134177660,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b440e8ac5a3fdc8c2a96587abfbb7872e5470ae85fef17b965b53ed89f268e0e"
    }
  },
  {
    "ts": null,
    "headline": "Amgen quarterly profit tops Wall Street view, sales up 11%",
    "summary": "Amgen on Thursday said itsfirst-quarter profit rose 24%, handily exceeding Wall Streetexpectations, as product sales increased 11% and profit marginswidened. Shares of the...",
    "url": "https://finnhub.io/api/news?id=619a4e3f9ffd6d4fabd30767e1f8499e5a1d326c203abd611f5613b862f95d6a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746118863,
      "headline": "Amgen quarterly profit tops Wall Street view, sales up 11%",
      "id": 134177553,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "Amgen on Thursday said itsfirst-quarter profit rose 24%, handily exceeding Wall Streetexpectations, as product sales increased 11% and profit marginswidened. Shares of the...",
      "url": "https://finnhub.io/api/news?id=619a4e3f9ffd6d4fabd30767e1f8499e5a1d326c203abd611f5613b862f95d6a"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1edbf696343e3c191b09e9a24b0dfa09a6e859af5a8fce046ced5aa5b7b673a1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117300,
      "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "id": 134190307,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1edbf696343e3c191b09e9a24b0dfa09a6e859af5a8fce046ced5aa5b7b673a1"
    }
  },
  {
    "ts": null,
    "headline": "Amgen : Q1 2025 - Earnings Call Slides FINAL",
    "summary": "Q1 '25 Earnings Call ...",
    "url": "https://finnhub.io/api/news?id=e9c5ce243b5f5c1ac00b73bbd1e740e9a5e92661a58031ec1a7a0069da3caa61",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746116490,
      "headline": "Amgen : Q1 2025 - Earnings Call Slides FINAL",
      "id": 134177070,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "Q1 '25 Earnings Call ...",
      "url": "https://finnhub.io/api/news?id=e9c5ce243b5f5c1ac00b73bbd1e740e9a5e92661a58031ec1a7a0069da3caa61"
    }
  },
  {
    "ts": null,
    "headline": "Amgen 1Q Revenue Up 9% as Many Products Deliver Double-Digit Sales Growth",
    "summary": "By Roshan Fernandez Amgen first-quarter revenue and profit rose after the biotechnology company said 14 of its products delivered at least double-digit sales growth. The Thousand Oaks,...",
    "url": "https://finnhub.io/api/news?id=d5fb5afd828f982d33bc83b4b50c3e9c73a976b18dc1c6509c4bb3c5c58d30b2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746116246,
      "headline": "Amgen 1Q Revenue Up 9% as Many Products Deliver Double-Digit Sales Growth",
      "id": 134176998,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "By Roshan Fernandez Amgen first-quarter revenue and profit rose after the biotechnology company said 14 of its products delivered at least double-digit sales growth. The Thousand Oaks,...",
      "url": "https://finnhub.io/api/news?id=d5fb5afd828f982d33bc83b4b50c3e9c73a976b18dc1c6509c4bb3c5c58d30b2"
    }
  },
  {
    "ts": null,
    "headline": "AMGEN : REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS (amgen reports first quarter 2025 financial results)",
    "summary": "THOUSAND OAKS, Calif., May 1, 2025/PRNewswire/ -- Amgen today announced financial results for the first quarter of 2025. Demand for our products was strong globally in the first...",
    "url": "https://finnhub.io/api/news?id=0cedd9f556f3106a61598025d0c79374e03f4804e04fe66b4187a54e55aea819",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746115569,
      "headline": "AMGEN : REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS (amgen reports first quarter 2025 financial results)",
      "id": 134176775,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "THOUSAND OAKS, Calif., May 1, 2025/PRNewswire/ -- Amgen today announced financial results for the first quarter of 2025. Demand for our products was strong globally in the first...",
      "url": "https://finnhub.io/api/news?id=0cedd9f556f3106a61598025d0c79374e03f4804e04fe66b4187a54e55aea819"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Amgen Inc., Q1 2025 Earnings Call, May 01, 2025",
    "summary": "Presentation Operator MessageOperator My name is Julianne, and I will be your conference facilitator today for the Amgen's Q1 FY 2025 Earnings Conference Call. [Operator Instructions] I would now",
    "url": "https://finnhub.io/api/news?id=018ab1a6d04ba1a0b1d35ebc65c7abce10fca9bee10c2b383ec34b23c8f2d5ca",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746109680,
      "headline": "Transcript : Amgen Inc., Q1 2025 Earnings Call, May 01, 2025",
      "id": 135882013,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "Presentation Operator MessageOperator My name is Julianne, and I will be your conference facilitator today for the Amgen's Q1 FY 2025 Earnings Conference Call. [Operator Instructions] I would now",
      "url": "https://finnhub.io/api/news?id=018ab1a6d04ba1a0b1d35ebc65c7abce10fca9bee10c2b383ec34b23c8f2d5ca"
    }
  },
  {
    "ts": null,
    "headline": "Beat the Nasdaq With This Cash-Gushing Dividend Stock",
    "summary": "Shares of Amgen have rallied at the start of 2025 despite the broader stock market sell-off.  Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence.  Biotech giant Amgen (NASDAQ: AMGN) exemplifies this strategy with its 3.3% dividend yield, supported by steady growth and rock-solid fundamentals.",
    "url": "https://finnhub.io/api/news?id=85b05d1cf220425df9d60cf0837b7e86d6a043f564f49ea7a3bfedef5b680cc8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746102600,
      "headline": "Beat the Nasdaq With This Cash-Gushing Dividend Stock",
      "id": 134171771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Shares of Amgen have rallied at the start of 2025 despite the broader stock market sell-off.  Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence.  Biotech giant Amgen (NASDAQ: AMGN) exemplifies this strategy with its 3.3% dividend yield, supported by steady growth and rock-solid fundamentals.",
      "url": "https://finnhub.io/api/news?id=85b05d1cf220425df9d60cf0837b7e86d6a043f564f49ea7a3bfedef5b680cc8"
    }
  }
]